Optimizing Economic Evaluation of First-Line Chemotherapies for Metastatic Pancreatic Cancer for the UK and the US
Pancreatic cancer is the fourth leading cause of cancer-related mortality in the United Kingdom (UK) and the United States (US). Most of the cases are diagnosed in the metastatic stage (MPC) and the disease is associated with a significant economic and quality of life burden. Chemotherapy with gemci...
Main Author: | |
---|---|
Other Authors: | |
Language: | en_US |
Published: |
The University of Arizona.
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/621294 http://arizona.openrepository.com/arizona/handle/10150/621294 |